Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP654807.RA4GptmZP-AdsfPOjZ6BtKclpAddiK1pMeNdAYv3q-jHA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP654807.RA4GptmZP-AdsfPOjZ6BtKclpAddiK1pMeNdAYv3q-jHA130_assertion type Assertion NP654807.RA4GptmZP-AdsfPOjZ6BtKclpAddiK1pMeNdAYv3q-jHA130_head.
- NP654807.RA4GptmZP-AdsfPOjZ6BtKclpAddiK1pMeNdAYv3q-jHA130_assertion description "[The demonstration of cross-lineage rearrangement of both Ig and TCR genes lends support to evidence from G6PD alloenzyme studies that the target of transformation in aCML is an early stem cell not yet irreversibly committed to myeloid differentiation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP654807.RA4GptmZP-AdsfPOjZ6BtKclpAddiK1pMeNdAYv3q-jHA130_provenance.
- NP654807.RA4GptmZP-AdsfPOjZ6BtKclpAddiK1pMeNdAYv3q-jHA130_assertion evidence source_evidence_literature NP654807.RA4GptmZP-AdsfPOjZ6BtKclpAddiK1pMeNdAYv3q-jHA130_provenance.
- NP654807.RA4GptmZP-AdsfPOjZ6BtKclpAddiK1pMeNdAYv3q-jHA130_assertion SIO_000772 1826535 NP654807.RA4GptmZP-AdsfPOjZ6BtKclpAddiK1pMeNdAYv3q-jHA130_provenance.
- NP654807.RA4GptmZP-AdsfPOjZ6BtKclpAddiK1pMeNdAYv3q-jHA130_assertion wasDerivedFrom befree-2016 NP654807.RA4GptmZP-AdsfPOjZ6BtKclpAddiK1pMeNdAYv3q-jHA130_provenance.
- NP654807.RA4GptmZP-AdsfPOjZ6BtKclpAddiK1pMeNdAYv3q-jHA130_assertion wasGeneratedBy ECO_0000203 NP654807.RA4GptmZP-AdsfPOjZ6BtKclpAddiK1pMeNdAYv3q-jHA130_provenance.